According to Kymera Therapeutics's latest financial reports the company's current revenue (TTM) is €79.9 M. In 2023 the company made a revenue of €71.09 M an increase over the revenue in the year 2022 that were of €43.65 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.